Caged Cyclofen-OH Synthesis Yield and Scalability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing caged precursors of cyclofen-OH and its derivatives have low yields, making them unsuitable for large-scale production and requiring costly purification steps, which are not compatible with scaling up for applications in animal models like mice.

Innovation Solution

A new process involving McMurry coupling, phenol monosubstitution, and alkylation steps to introduce the cyclohexyl ring and caging moiety, with optimized conditions to improve overall yields and reduce the need for sensitive purification, allowing for reproducible and scalable synthesis of caged cyclofen-OH and derivatives.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional synthesis routes (McMurry coupling followed by phenol monosubstitution and Mitsunobu reaction) are used, then caged precursors can be produced, but the overall yield is low (22%, 9.6%, and 11% for different compounds)

Engineering Contradiction:
Improveoverall yieldVSAvoidmanufacturing complexity
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The synthesis is divided into distinct modular steps: McMurry coupling to form intermediate (A), phenol monosubstitution to form intermediate (C), and alkylation to form final compound (I). Each step can be independently optimized and scaled, improving overall yield while maintaining manufacturability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The McMurry coupling step is performed first to establish the core structure with high yield (85-95%), creating a stable intermediate that facilitates subsequent high-yield transformations. This preliminary structuring enables better control over final product yield.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If traditional synthesis routes are used, then caged precursors can be produced, but the process is not reproducible and not suitable for large-scale production

Engineering Contradiction:
ImprovescalabilityVSAvoidreproducibility
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

Reaction parameters are optimized for each step: McMurry coupling uses specific TiCl4/Zn ratios and temperature control; phenol substitution uses controlled base equivalents and solvent systems; alkylation uses optimized temperature profiles. These parameter standardizations ensure reproducible results across scales.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The traditional Mitsunobu reaction is replaced with a simpler alkylation reaction that avoids complex reagent systems (DIAD, PPh3) and provides more consistent, scalable results with fewer side reactions requiring purification.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If HPLC purification is performed to ensure low cyclofen-OH content (<2%), then product purity is improved, but the process becomes incompatible with scale-up

Engineering Contradiction:
ImprovepurityVSAvoidscale compatibility
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The problematic Mitsunobu reaction step that generates difficult-to-remove byproducts and requires HPLC purification is completely removed from the synthesis route. The replacement alkylation step produces cleaner reactions that can be purified by standard methods suitable for scale-up.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The synthesis route is redesigned to avoid expensive, low-throughput purification methods (HPLC) in favor of simpler, scalable purification techniques. The process accepts minor impurities that can be removed by standard chromatography or filtration, making scale-up economically viable.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Manufacturing precision

If multiple purification steps are performed to remove residual inducer, then product purity is improved, but time and cost increase significantly

Engineering Contradiction:
ImprovepurityVSAvoidpurification time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The synthesis route is designed so that the reaction chemistry itself minimizes the formation of difficult-to-remove impurities. The alkylation reaction conditions are selected to avoid side products that would require extensive purification, turning a potential harm (impurity formation) into a benefit (clean reaction profile).

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new process achieves yields of over 30%, doubling the previous methods' yields, making it suitable for large-scale production without the need for extensive purification, thus enabling the production of caged precursors for demanding applications.

Implementation Method 1

a first step of McMurry coupling enables to introduce the cyclohexyl ring on 4,4'-dihydroxybenzophenone

Methodology Applied
Scientific EffectMcMurry coupling: Chemical Bonding

Implementation Method 2

The second step introduces the caging arylalkyl moiety by phenol monosubstitution

Methodology Applied
Scientific EffectPhenol monosubstitution: Chemical Bonding

Implementation Method 3

The second phenol group is then alkylated

Methodology Applied
Scientific EffectAlkylation: Chemical Bonding

Data Source

PatentEP3266771B1Synthesis of photoactivable caged cyclofen-oh and derivatives thereof
Publication Date: 2019.02.20 PARIS SCI & LETTRES QUARTIER LATIN
  • EP3266771B1 patent drawingFigure 1
  • EP3266771B1 patent drawing
  • EP3266771B1 patent drawing

AI summary

The present invention relates to a new process of manufacturing of caged cyclofen-OH of formula (I) and derivatives or salts thereof, wherein n, R1, R1', R2, and R3 are as defined in the claims.